The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and Clinical Studies. [electronic resource]
- Current cancer drug targets 2018
- 720-736 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1873-5576
10.2174/1568009617666170630124643 doi
Acetylation Animals Antineoplastic Agents--adverse effects Digestive System Neoplasms--drug therapy Drug Combinations Drug Therapy, Combination Histone Deacetylase Inhibitors--adverse effects Histone Deacetylases--classification Histones--metabolism Humans Mice Panobinostat--adverse effects Proteasome Inhibitors--therapeutic use Protein Kinase Inhibitors--therapeutic use Treatment Outcome